Dr. Lal PathLabs
Signals mentioning Dr. Lal PathLabs
- Dr Lal PathLabs may raise FY27 margin guidance after first-half results
- Dr Lal PathLabs beats in Q1; ICICI lifts target to Rs 1,690 but cuts rating to Hold
- Orange Health Labs hits Rs 180 cr ARR as 30-minute home sampling scales across four metros
- Orange Health Labs hits ₹180 cr ARR betting diagnostics is the next quick-commerce category
- Orange Health Labs hits ₹180 cr ARR pitching 60-min collection, 6-hr reports against Dr Lal, Metropolis